The Global Biosimilars Summit

PARITY Where equivalence meets opportunity

The commercial and scientific meeting place for every stakeholder shaping the next era of biosimilars.

September 21–23, 2027Philadelphia, Pennsylvania
Register earlyExplore the agendaSubmit a proposal
Analytical Similarity Global Regulation Interchangeability Clinical Development Manufacturing Scale-Up CDMO Partnerships Market Access Pricing & Adoption Patent Strategy Licensing & Investment 1:1 Partnering

Built for outcomes

Not another policy conference.

PARITY is designed around the decisions that move biosimilar programs forward: who to build with, how to enter, what to license, and where to invest.

The global biosimilars market is entering its defining decade. With a wave of blockbuster biologics approaching loss of exclusivity, technical excellence is only part of the equation. Commercial readiness, manufacturing partnerships, payer strategy, and capital access now decide who leads.

For three days in Philadelphia, PARITY brings the full ecosystem under one roof to compare evidence, pressure-test strategy, and make the connections that continue after the program ends.

Why PARITY, why now

Three days, one continuum

A program built to move from insight to action.

21SEP
2027

Day 01

Science & regulation

Analytical similarity, interchangeability, clinical design, and the global pathways shaping approval.

View Day 1
22SEP
2027

Day 02

Manufacturing & market

Scale, CDMO strategy, pricing, payer response, patent strategy, licensing, and investment.

View Day 2
23SEP
2027

Day 03

Partnering & outlook

Pre-scheduled one-to-one meetings, deal rooms, and a forward view of the next five years.

View Day 3

The room you need

Every critical voice in the biosimilars value chain.

A deliberate delegate mix means each conversation has context: science meets manufacturing, access meets policy, and opportunity meets capital.

Develop

Developers & manufacturers

Originator divisions, pure-play developers, and biotechnology teams building the next portfolio.

30% target share

Scale

CDMOs & supply partners

Process development, scale-up, technology transfer, quality, and commercial manufacturing leaders.

20% target share

Access & capital

Payers, licensing & investors

Market access strategists, business development executives, analysts, and capital partners.

Commercial ecosystem

Govern

Regulatory, legal & policy

FDA, CMS, global agency representatives, regulatory leaders, and BPCIA specialists.

The operating framework

Partnering is the program

Leave with more than notes.

Browse attendee profiles, request the meetings that matter, and arrive with a schedule built around your priorities.

4.5hdedicated partnering time
20 minpre-scheduled meeting slots
01Browse profiles
02Request meetings
03Arrive scheduled

Sponsor-hosted deal rooms and focused investor briefings create space for conversations that need more than a hallway introduction.

Secure your place

Philadelphia · September 2027

At the center of the US biopharma corridor.

Within reach of New Jersey, New York, Washington DC, and the region’s densest concentration of biopharma decision makers.

Philadelphia, Pennsylvania
Venue confirmation expected January 2027
Travel and hotel details will follow

Get venue updates